About NodThera
nodthera is developing a new class of potent and highly selective nlrp3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. we’re building a dynamic... Read more
nodthera is developing a new class of potent and highly selective nlrp3 inflammasome inhibitors for the treatment of diseases driven by chronic inflammation. we’re building a dynamic... Read more